![](https://www.diabetesnews.com/wp-content/uploads/2014/03/diabetes_mellitus_-_insulin_treatment-2-150x150.jpg)
Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.
Read more
Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.
Read more